EML4–ALK rearrangement in squamous cell carcinoma shows significant response to anti-ALK inhibitor drugs crizotinib and alectinib

Overview of attention for article published in Cancer Chemotherapy and Pharmacology, April 2018

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 7 Dimensions

Readers on

mendeley: 9 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 66 followers.

one of the rare cases of ALK inhibitor treatment with response in squamous cell carcinoma #lungcancer #cancer https://t.co/mqKgug4yVl

Reply Repost Favourite